Regulatory Strategies To Leverage New and Rapidly Evolving Accelerated Pathways
Learn about the following topics from PAREXEL Consulting experts in this recorded webinar: 1. Opportunities and challenges presented by accelerated pathway designations; 2. FDA frameworks for developing targeted therapies; 3. How to leverage intermediate clinical endpoints and novel biomarkers; 4. How to use real world evidence and patient preference data; and 5. The importance of early engagement with EU regulators and payers.